Interrelations of Cumulative Social Risk, Silent Myocardial Infarction, and Mortality in the General Population

Nikhil Patel1, Muhammad Imtiaz Ahmad2, Wei Zhang3

  • 1Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Insights

Cumulative social risk (CSR) increases silent myocardial infarction (SMI) risk. The combination of CSR and SMI significantly elevates mortality risk more than CSR alone, highlighting a critical public health concern.

Area of Science:

  • Public Health
  • Cardiology
  • Sociology

Background:

  • Cumulative social risk (CSR) is linked to increased cardiovascular mortality.
  • The association between CSR and silent myocardial infarction (SMI) prevalence and its impact on mortality is not well understood.

Purpose of the Study:

  • To investigate the association between CSR and prevalent SMI.
  • To determine if the combined presence of CSR and SMI predicts mortality more than CSR in isolation.

Main Methods:

  • Analysis of 6,708 participants from the National Health and Nutrition Examination Survey (NHANES III).
  • CSR score calculated based on poverty, race, education, and living situation.
  • SMI defined by electrocardiographic evidence without clinical symptoms.
  • Multivariable logistic and Cox proportional hazards regression models used.

Main Results:

  • Higher CSR (≥3) was associated with increased SMI prevalence (OR 2.21).
  • CSR combined with SMI showed significantly higher mortality risk compared to CSR alone across all CSR levels (HRs ranging from 1.21 to 2.06).

Conclusions:

  • Exposure to cumulative social risk is associated with a higher prevalence of silent myocardial infarction.
  • The co-occurrence of SMI and CSR significantly increases mortality risk, emphasizing the need for interventions targeting social determinants of cardiovascular health.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
242
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
276
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
291